Anest. intenziv. Med. 2012;23(1):6-13

Use of neuromuscular blocking agents in general anaesthesia for surgery: A three-month, single-centre study in a Czech regional hospitalAnaesthesiology - Original Paper

Herold Ivan1,*, Sittová Naděžda1, Čurdová Marcela1, Adamus Milan2
1 Anesteziologicko-resuscitační oddělení, Oblastní nemocnice Mladá Boleslav, a. s.
2 Klinika anesteziologie, resuscitace a intenzivní medicíny, Fakultní nemocnice a Lékařská fakulta Univerzity Palackého v Olomouci

Objective:
Use of NMBAs in surgical anaesthesia.

Design:
Single-center, three-month analysis of anaesthesia charts (MBrelax2008).


Setting:
Department of Anaesthesiology and Intensive Care of a regional general hospital.

Materials and methods:
The observed parameters in surgical anaesthesia included the use of general anaesthesia (GA), regional anaesthesia (RA), suxamethonium and non-depolarising NMBAs. The results were compared to data from the observational one-day Czech Anesthesia Day (CAD2010).

Results:
Total 2316 anaesthesia charts from the observed period were evaluated. GA was used in 72.6 % (CAD2010 92.9 %, p < 0.0001). Orthopaedics/Trauma (366; 48.8 %), General Surgery (343; 80.3 %), Urology (248; 72.9 %), ENT (306; 100 %), Gynae/Obstetrics (406; 84.4 %) and Ophthalmology (12; 100 %). NMBAs were administered to 634 patients (37.7% vs 54.7% in CAD2010, p < 0.0001), most often in G/S (271; 79 %). LMA was inserted without facilitation by NMBAs in 478 (28.4 %) patients. Suxamethonium alone was used in 33 patients (2 % GA) only, most frequently in G/O. In the MBrelax2008 study, non-depolarizing NMBAs only were administered to 471 patients (28 % GA) vs. 684 (36.1% GA) in CAD2010 (p < 0.0001). Rocuronium was administered more often than cisatracurium (20.8 % vs. 13.8 %, p < 0.0001).

Conclusion:
Comparing with CAD2010, surgery was performed under GA less frequently, reflecting increasing preference of RA in the center. This correlates with the lower use of NMBAs. LMA were more often inserted without NMBAs. Rocuronium is the most frequently used NMBA. The results point to the difficulties experienced when comparing the data from observational multi-center studies with current clinical practice. The data should be evaluated for longer periods and comparable centers.

Keywords: general anaesthesia; regional anaesthesia; pharmaco-economics; NMBA; suxamethonium; rocuronium; cisatracurium

Received: January 5, 2012; Accepted: January 15, 2012; Published: February 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Herold I, Sittová N, Čurdová M, Adamus M. Use of neuromuscular blocking agents in general anaesthesia for surgery: A three-month, single-centre study in a Czech regional hospital. Anest. intenziv. Med. 2012;23(1):6-13.
Download citation

References

  1. Loughlin, K. A. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room. Pharmacotherapy, 1996, 16, p. 942. Go to original source... Go to PubMed...
  2. Chambers, D., Paulden, M., Paton, F., Heirs, M., Duffy, S., Craig, D. et al. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment. Health Technol. Assess., 2010, 14, 39, p. 1-211. Go to original source... Go to PubMed...
  3. Paton, F., Paulden, M., Chambers, D., Heirs, M., Duffy, S., Hunter. J. M., Sculpher, M., Woolacott, N. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Br. J. Anaesth., 2010, 105, 5, p. 558-567. Go to original source... Go to PubMed...
  4. Naguib, M., Kopman, A. F., Lien, C. A., Hunter, J. M., Lopez, A., Brull, S. J. A survey of current neuromuscular block in the United States and Europe. Anesth. Analg., 2010, 111, p. 110-119. Go to original source... Go to PubMed...
  5. Murphy, G. S., Szokol, J. W., Marymont, J. H., Greenberg, S. B., Avram, M. J., Vender, J. S. Residual Neuromuscular Blockade and Critical Respiratory Events in the Postanesthesia Care Unit. Anesth. Analg., 2008, 107, p. 130-137. Go to original source... Go to PubMed...
  6. Brull, S., Naguib, M., Miller, R. Residual Neuromuscular Block: Rediscovering the Obvious. Anesth. Analg., 2008, 107, p. 11-14. Go to original source... Go to PubMed...
  7. The Joint commission: Sentinel Event Alert, Issue 32 2 - October 6, 2004. Preventing, and managing the impact of, anesthesia awareness. Dostupné na: http://www.jointcommission.org/assets/1/18/SEA_32.PDF
  8. Černý, V., Adamus, M., Cvachovec, K., Ševčík, P., Herold, I. Anestezie v České republice 2010 - jednodenní prospektivní observační dotazníková studie. Anest. intenziv. Med., 2011, 22, s. 5-12.
  9. Adamus, M., Herold, I., Cvachovec, K., Ševčík, P., Černý, V. Svalová relaxace během celkové anestezie v České republice 2010 - jednodenní prospektivní observační dotazníková studie. Anest. intenziv. Med., 2011, 22, s. 82-89.
  10. Drábková, J. Statistika oboru anesteziologie a resuscitace (2010). Anest. intenziv. Med., 2011, 22, p. 233-238.
  11. Lee, C. L. Goodbye Suxamethonium! Anaesthesia, 2009, 64, S1, p. 73-81. Go to original source... Go to PubMed...
  12. Umesh, G., Jasvinder, K., Shetty, N. Suxamethonium stands the test of time: it is too early to say goodbye. Anaesthesia, 2009, 64, p. 1023. Go to original source... Go to PubMed...
  13. Cerny, V., Herold, I., Cvachovec, K., Sevcik, P., Adamus, M. Guidelines for managing neuromuscular block: not only Czech beer deserves a taste. Anesth. Analg., 2011, 112, p. 482. Go to original source... Go to PubMed...
  14. Herold, I. Myorelaxancia v dětské anesteziologii. In Gašparec, P. et al. Princípy detskej anestézie. 1. vydání. Martin: Osveta, 2010, p. 76-88. ISBN 978-80-8063-340-0.
  15. Herold, I. Svalová relaxancia v anesteziologii a intenzivní péči. 1. vydání. Praha: Maxdorf, 2004, 268 s. ISBN 80-7345-025-0.




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.